• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Sucampo Pharmaceuticals, Inc. (SCMP)

    -NasdaqGM
    15.06 Down 0.90(5.64%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:15.96
    Open:15.87
    Bid:11.52 x 400
    Ask:15.95 x 100
    1y Target Est:16.20
    Beta:2.82
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:15.04 - 16.13
    52wk Range:5.80 - 16.50
    Volume:273,149
    Avg Vol (3m):327,806
    Market Cap:659.70M
    P/E (ttm):116.74
    EPS (ttm):0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SCMP

    Comparison

    Symbol% ChgMkt Cap
    SCMPDown 5.64%659.70M
    IRWDDown 2.87%2.18B
    PGNXDown 4.32%415.94M
    THRXDown 0.44%1.30B

    Key Statistics

    Forward P/E (1 yr):25.10
    P/S (ttm):6.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.47
    Quarterly EPS Est (Dec-14) :0.23
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, discovery, development, and commercialization of proprietary drugs based on prostones and other drug technologies in the Americas, Europe, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback